Successful treatment of right-sided native valve methicillin-resistant Staphylococcus aureus endocarditis and septicaemia with teicoplanin and rifampicin: A case report

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 7, 2012, Pages 544-547

  Saravu, Kavitha ^a   Mukhopadhyay, Chiranjay ^b   Satyanarayanan, Vishwanath ^a   Pai, Ananth ^a   Komaranchath, Ashok Sebastian ^a   Munim, Frenil ^b   Shastry, Barkur Ananthakrishna ^a   Tom, Devasia ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

^b MANIPAL UNIVERSITY   (India)

Author keywords

Infective endocarditis; Methicillin resistant Staphylococcus aureus; Rifampicin; Teicoplanin; Vancomycin

Indexed keywords

CLINDAMYCIN; GLUCOSE; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M; INOTROPIC AGENT; PIPERACILLIN PLUS TAZOBACTAM; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN;

ACIDOSIS; ADULT; ALCOHOLISM; ANION GAP; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; BLOOD GAS ANALYSIS; CASE REPORT; CONSERVATIVE TREATMENT; DRUG EFFICACY; DYSPNEA; ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEMODIALYSIS; HEPATITIS B; HUMAN; HYPERKALEMIA; HYPOTENSION; INDIAN; KETONURIA; KIDNEY FAILURE; KIDNEY FUNCTION; LEUKOCYTOSIS; LOW DRUG DOSE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; REPEAT PROCEDURE; SMOKING; STUPOR; TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY; TREATMENT DURATION; TRICUSPID VALVE DISEASE; TRICUSPID VALVE REGURGITATION; VOMITING;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; HUMANS; INDIA; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RENAL INSUFFICIENCY; RIFAMPIN; SEPSIS; STAPHYLOCOCCAL INFECTIONS; TEICOPLANIN; TREATMENT OUTCOME;

EID: 84862540760     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.657233     Document Type: Article

References (13)

1. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298: 1763-71. (Pubitemid 47598444)
2. Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005;293:3012-21. (Pubitemid 40965071)
3. Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2005;41:507-14. (Pubitemid 41099645)
4. Nathwani D, Morgan M, Masterton RG, Dryden M, Cookson BD, French G, et al. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008;61:976-94. (Pubitemid 351545546)
5. Maclayton DO, Hall RG 2nd. Pharmacologic treatment options for nosocomial pneumonia involving methicillinresistant Staphylococcus aureus. Ann Pharmacother 2007; 41:235-44. (Pubitemid 46340054)
6. Rybak MJ, Lomaestro BM, Rotscahfer JC, Moellering RC, Craig WA, Billeter M, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009;49:325.
7. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18-55.
8. Chang FY, Peacock JE Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 2003;82:333.
9. Silverman JA, Mortin LI, Van Praagh AD, Li T, Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis 2005;191:2149.
10. Svetitsky S, Leibovici L, Paul M. Comparative effi cacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother 2009;53: 4069-79.
11. Schaison G, Graninger W, Bouza E. Teicoplanin in the treatment of serious infection. J Chemother 2000;12:26-33.
12. Murray BE, Nannini EC. Glycopeptides (teicoplanin and vancomycin), streptogramins (quinupristin-dalfopristin), and lipopeptides (daptomycin). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases. Vol. 1. 7 th ed. Philadelphia: Elsevier Inc.; 2010 pp. 449-67.
13. Cavalcanti AB, Goncalves AR, Almeida CS, Bugano DD, Silva E. Teicoplanin versus vancomycin for proven or suspected infection. Cochrane Database Syst Rev 2010(6):CD007022.